Latest Sales And Development News

Page 1 of 5
Lark Distilling reported 15.1% FY26 sales growth and entered FY27 debt-free, but shareholders delivered a sharp rebuke on executive pay and director fees. The company now has to turn its new production platform, Signature range and international push into positive operating cash flow.
Victor Sage
Victor Sage
19 Nov 2026
Optiscan has moved its InForm and InVue medical-imaging devices into formal US FDA review after a quarter of intensive regulatory and clinical work. The milestone comes with $11.093 million in cash and a reported 3.5 quarters of funding at the latest operating burn rate.
Victor Sage
Victor Sage
30 Oct 2026
Cochlear has reaffirmed FY27 underlying net profit guidance of $330 million to $350 million after a disappointing FY26, while pointing to strong Nexa adoption and progress on fully implantable hearing technology. The company is cutting fixed costs and expanding medical referral pathways as it seeks to convert a large pool of untreated adult hearing loss into growth.
Victor Sage
Victor Sage
26 Oct 2026
Elevra Lithium has completed the sale of its Ghanaian Ewoyaa project interest to Zhejiang Huayou Cobalt for US$71 million in cash before fees and taxes. The deal removes its development funding obligations and transfers its spodumene offtake rights, leaving the company more focused on its North American portfolio.
Maxwell Dee
Maxwell Dee
26 Oct 2026
Firebrick Pharma is escalating Nasodine’s US push from online sales into retail pharmacies while its September-quarter cash balance fell to A$875,000. The company reported a A$398,000 operating cash outflow and estimated 2.2 quarters of funding at the current rate.
Victor Sage
Victor Sage
23 Oct 2026
Green360 Technologies has moved MKX further into commercial supply, with binding agreements covering up to 9,600 tonnes and more than 3,500m³ of concrete placed in Melbourne projects. Revenue rose and operating cash outflow narrowed sharply, although the reported contract volumes are maximums rather than guaranteed purchases.
Victor Sage
Victor Sage
20 Oct 2026
Blackpearl Group narrowed its quarterly EBITDAF loss to $2.97 million and is now targeting profitability in Q1 FY28. The company has also secured a non-binding US distribution agreement with a potential pipeline of more than 70 enterprise customers.
Sophie Babbage
Sophie Babbage
20 Oct 2026
Lendlease and Bizzi & Partners have extended the deadline for conditions attached to the proposed sale of Lendlease’s MSG North development rights in Milan. Closing remains uncertain, with Lendlease warning it may need to fund approximately $160 million of project obligations if the transaction fails.
Victor Sage
Victor Sage
2 Oct 2026
Prophecy International’s revenue fell 15% and its statutory loss widened to $7.9 million in FY26, leaving the software group with $1 million in cash and negative net assets. A major restructure, new debtor finance facility and AI product launch offer a recovery plan, but the auditor has warned of material uncertainty around the company’s ability to continue as a going concern.
Victor Sage
Victor Sage
30 Sept 2026
Artrya has launched its AI-powered Salix® platform commercially in the US, securing three foundation health systems and raising $80 million to fuel growth. With FDA clearance for its Coronary Plaque module and a pivotal clinical study underway, the company is poised for scaling revenues amid a strong balance sheet.
Ada Torres
Ada Torres
1 Sept 2026
Atomo Diagnostics lifted revenue 41% to AUD 5.33 million for FY26, cutting its loss by 29% to AUD 3.51 million, driven by HIV self-testing growth and a key US partnership. Leadership changes signal a strategic pivot as the company eyes global expansion.
Ada Torres
Ada Torres
31 Aug 2026
Australis Oil & Gas Ltd posted a $2.6 million net loss for 1H 2026 amid sharply reduced production volumes but is progressing its Tuscaloosa Marine Shale development with a key partner and a planned Q4 well spud.
Maxwell Dee
Maxwell Dee
19 Aug 2026

Browse the archive

Full archive